Skip to Main Content

A Cambridge, Mass., biotech startup is using a new method to gauge the health of synapses in people’s brains as it prepares to test an experimental medicine to treat Alzheimer’s disease, the great white whale for drug makers.

Rodin Therapeutics said Thursday it has begun testing a recently developed radioactive chemical that binds with a protein present in synapses, structures that allow nerve cells to pass electrical or chemical signals to each other.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

  • I had an MRI done approx 2 weeks ago due to continued memory issues, also have seizures after contracting whooping cough 11 years ago from someone not vaccinated. The scan showed scattered white matter, I am 59 years old, can this be from the activity, severe lack of sleep or is this a sign of the beginning of EOD or Alzheimers?

Comments are closed.